RecruitingNot ApplicableNCT06409260

Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography

Objective Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography: A Randomized Study


Sponsor

Matias Vested

Enrollment

120 participants

Start Date

Jul 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to compare AMG and EMG (Philips IntelliVue NMT module and Senzime TetraGraph) in the objective monitoring of neuromuscular blocking in children between the age of 6 months and 2 years.The monitoring will be done bilaterally either on n.ulnaris or n. tibialis. The hypothesis of the study is that AMG will indicate faster recovery time (time to return to TOF 90%) from neuromuscular block than EMG.


Eligibility

Min Age: 6 MonthsMax Age: 2 Years

Inclusion Criteria3

  • Patients 6 months - 2 years of age
  • Scheduled for elective surgery under general anaesthesia with intubation and use of rocuronium
  • American Society of Anesthesiologists (ASA) physical status classification I to III

Exclusion Criteria4

  • Known allergy to rocuronium
  • Neuromuscular disease that may interfere with neuromuscular data
  • Indication for rapid sequence induction
  • Prone position

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAcceleromyography (AMG)

Philips IntelliVue NMT Module

OTHERElectromyography (EMG)

Senzime TetraGraph


Locations(1)

Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06409260


Related Trials